GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (OTCPK:DSKYF) » Definitions » 5-Year ROIIC %

DSKYF (Daiichinkyo Co) 5-Year ROIIC % : 13.60% (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Daiichinkyo Co's 5-Year ROIIC % for the quarter that ended in Mar. 2024 was 13.60%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Daiichinkyo Co's 5-Year ROIIC % or its related term are showing as below:

DSKYF's 5-Year ROIIC % is ranked better than
68.66% of 951 companies
in the Drug Manufacturers industry
Industry Median: 3.48 vs DSKYF: 13.60

Daiichinkyo Co 5-Year ROIIC % Historical Data

The historical data trend for Daiichinkyo Co's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co 5-Year ROIIC % Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.10 -30.08 8.88 10.62 13.60

Daiichinkyo Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 13.60 - -

Competitive Comparison of Daiichinkyo Co's 5-Year ROIIC %

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co's 5-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's 5-Year ROIIC % falls into.



Daiichinkyo Co 5-Year ROIIC % Calculation

Daiichinkyo Co's 5-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( 1196.6426373 (Mar. 2024) - 819.7056036 (Mar. 2019) )/( 10902.471 (Mar. 2024) - 8861.497 (Mar. 2019) )
=376.9370337/2040.974
=18.47%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Daiichinkyo Co  (OTCPK:DSKYF) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Daiichinkyo Co 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co Business Description

Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2023, approximately one third of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co Headlines